Viewing Study NCT06984133


Ignite Creation Date: 2025-12-25 @ 2:43 AM
Ignite Modification Date: 2025-12-29 @ 8:41 AM
Study NCT ID: NCT06984133
Status: RECRUITING
Last Update Posted: 2025-05-22
First Post: 2025-05-14
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Structured Education Program and Glycemic Control in Adolescents With Type 1 Diabetes
Sponsor: Dasman Diabetes Institute
Organization:

Study Overview

Official Title: Evaluating the Effectiveness of a Structured Educational Program on Glycemic Control in Adolescents With Type 1 Diabetes: A Randomized Controlled Trial
Status: RECRUITING
Status Verified Date: 2025-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Type 1 diabetes is becoming more common in Kuwaiti and Arab adolescents. Many young people with this condition struggle to keep their blood glucose levels under control, which can lead to diabetes-related complications and affect their quality of life.

The goal of this clinical trial is to evaluate the effectiveness of a structured educational program on glycemic control among Arab adolescents with type 1 diabetes aged 11 to 14 years.

Participants will be randomly assigned to one of two groups. The intervention group will receive the structured education program, and the control group will continue with standard care.

All participants will undergo assessments that include:

* collecting demographic and diabetes management data
* measuring weight and height
* measuring HbA1c levels and lipid profile
* filling out questionnaires on quality of life, carbohydrate and insulin dosing knowledge, physical activity
* collecting dietary intake
* providing AGP report

Participants in the intervention group will additionally be required to:

* attend the program for 4 consecutive days, one day for parents and three days for children
* fill out 3-day food diary records during the program
* attend a refresher course after 6 months

Participants in the control group will have the opportunity to participate in the program after approximately six months.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: